APA (7th ed.) Citation

L, W., Y, X., Y, Z., B, X., & L, Z. (2025). Bevacizumab reduces PD-L1 Not PD-1 inhibitor-associated pneumonitis in non-small cell lung cancer patients. Cancer immunology, immunotherapy : CII, 74(11), 334. https://doi.org/10.1007/s00262-025-04158-1

Chicago Style (17th ed.) Citation

L, Wang, Xu Y, Zhao Y, Xia B, and Zhu L. "Bevacizumab Reduces PD-L1 Not PD-1 Inhibitor-associated Pneumonitis in Non-small Cell Lung Cancer Patients." Cancer Immunology, Immunotherapy : CII 74, no. 11 (2025): 334. https://doi.org/10.1007/s00262-025-04158-1.

MLA (9th ed.) Citation

L, Wang, et al. "Bevacizumab Reduces PD-L1 Not PD-1 Inhibitor-associated Pneumonitis in Non-small Cell Lung Cancer Patients." Cancer Immunology, Immunotherapy : CII, vol. 74, no. 11, 2025, p. 334, https://doi.org/10.1007/s00262-025-04158-1.